Skip to main content

Table 3 Germline mutations identified in PABC cases

From: Germline mutations in a clinic-based series of pregnancy associated breast cancer patients

ID

Mutation (cDNA)

Mutation (protein)

Chromosome-Exon

Clinical Significance

Family History

#553

BRCA1 c.5328delC

p.Thr1777fs

chr17 exon 21

Pathogenic

2nd degree relative: Vulvar cancer

#964

BRCA1 c.3700_3704delGTAAA

p.Val1234Glnfs

chr17- exon 11

Pathogenic

No

#749

BRCA1 c.3700_3704delGTAAA

p.Val1234Glnfs

chr17- exon 11

Pathogenic

2nd degree relatives: Breast, Endometrial cancer

#750

BRCA1 c.5212G > A

p.Gly1738Arg

chr17- exon 20

Pathogenic

2nd degree relatives: Breast, Ovarian cancer

#2754

BRCA1 c.5251C > T

p.Arg1751X

chr17- exon 20

Pathogenic

2nd degree relatives: Breast, Prostate cancer, BCC

#2740

BRCA1 g.169527_180579del11052

p.Gly1803_Tyr1863del11052

chr17- exons 23,24

Pathogenic

2nd degree relatives: Endometrial, Lung cancer

#1927

CHEK2 c.1100delC

p.Thr367MetfsX1

chr22-exon10

Pathogenic

No

#3227

BRCA2 c.8386C > T

p.Pro2796Ser

chr13 exon 18

VUS

No

#1045

CHEK2 c.1175C > T

p.Ala392Val

chr22- exon 20

VUS

No

#2122

BRIP1 c.2285G > A

p.Arg762His

chr17- exon 1

VUS

1st degree relative: Prostate cancer

2nd degree relative: Breast cancer

  1. Note: Participants are identified by patient registry number along with their mutation and family history of cancer including hereditary breast and ovarian cancer syndrome (HBOC) – cancers, Basal cell carcinoma (BCC) of the skin, Variants of Unknown Significance (VUS), c. = coding DNA sequence, g. = genomic sequence, p. = protein sequence